​

Lunai Bioworks Stock (NASDAQ:LNAI)


Chart

Previous Close

$0.16

52W Range

$0.14 - $13.28

50D Avg

$1.61

200D Avg

$2.91

Market Cap

$829.68K

Avg Vol (3M)

$405.97K

Beta

0.35

Div Yield

-

LNAI Company Profile


Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

12

IPO Date

Sep 30, 2025

Website

LNAI Performance


Peer Comparison


TickerCompany
ICUSeaStar Medical Holding Corporation
BLRXBioLineRx Ltd.
GOVXGeoVax Labs, Inc.
LPCNLipocine Inc.
ERNAErnexa Therapeutics Inc.
APLMApollomics, Inc.
MBRXMoleculin Biotech, Inc.
ADAPAdaptimmune Therapeutics plc
THARTharimmune, Inc.
ANLAdlai Nortye Ltd.